Journal article
The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation
Abstract
At our institution, the cytomegalovirus (CMV) prophylaxis protocol for allogeneic bone marrow transplant (BMT) recipients who are CMV-seropositive or receive marrow from a CMV-seropositive donor consists of a surveillance bronchoscopy approximately 35 days post-transplant. Patients with a positive surveillance bronchoscopy for CMV receive pre-emptive ganciclovir. In order to determine the utility of other screening methods for CMV, we …
Authors
Humar A; O’Rourke K; Lipton J; Messner H; Meharchand J; Mahony J; Walker I; Wasi P; McGeer A; Moussa G
Journal
Bone Marrow Transplantation, Vol. 23, No. 1, pp. 45–51
Publisher
Springer Nature
Publication Date
January 1, 1999
DOI
10.1038/sj.bmt.1701525
ISSN
0268-3369